INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

77,709 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BB
Borgeson BlakeDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$93K
30.0K sh
Apr 7, 2026Apr 8, 2026
Page 1184 of 1943
← PrevNext →
traded Apr 7, 2026
+1d
SEC Form 4

Evidence

9
PN
Parent Haughey NicoleDirector
XPOFXponential Fitness, Inc.
Grant or award
A—
1,542 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
PF
Paolini John F.CHIEF MEDICAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,497 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
PF
Paolini John F.CHIEF MEDICAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,497 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

9
MR
McCrystle Kevin RossCOO
GAMBGRANDSTAND Ltd
Option exercise
M$38K
10.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
GC
Gowasack Andrew CarlDirector, President
IDAIT Stamp Inc
Option exercise
M—
86.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
SA
Stone Melissa AnnEVP and Interim CFO
PVHPVH CORP. /DE/
Tax withholding
F$18K
218 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
GW
Graf Erik W.EVP, Controller
PVHPVH CORP. /DE/
Tax withholding
F$5,254
65 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
BA
Beck Bryan AndrewChief Accounting Officer
HOGHARLEY-DAVIDSON, INC.
Grant or award
A—
7,143 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MT
Ming TracyFinancial Controller
IDAIT Stamp Inc
Option exercise
M—
3,286 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$273K
5,200 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

9
SA
Subrahmanyam AmbaChief People Officer
PVHPVH CORP. /DE/
Tax withholding
F$43K
537 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
BT
Beer Michael ThomasChief Financial Officer
NRGVEnergy Vault Holdings, Inc.
Option exercise
M—
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
SA
Subrahmanyam AmbaChief People Officer
PVHPVH CORP. /DE/
Tax withholding
F$47K
581 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
SD
Suva James DCFO
VELOVelo3D, Inc.
Grant or award
A—
135.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
TE
Tessari EbenCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,726 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
ME
Mark Martin EliasCFO
GAMBGRANDSTAND Ltd
Option exercise
M$44K
11.5K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$515K
10.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

9
GN
Genner Gareth NevilleDirector, Chief Executive Officer
IDAIT Stamp Inc
Option exercise
M—
106.6K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
WR
Wilson Lance RobertChief Financial Officer
IDAIT Stamp Inc
Tax withholding
F$694
267 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
FS
Francis Andrew ScottChief Technology Officer
IDAIT Stamp Inc
Option exercise
M—
64.2K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

9
WI
Winkles IsabelleChief Financial Officer
BRZEBraze, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
8,274 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$180K
3,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

8
TR
Taylor Ben RChief Financial Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Tax withholding
F$149K
48.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
BJ
Balance Austin JChief Product Officer
GRNDGrindr Inc.
Tax withholding
F$163K
13.4K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
BT
Beer Michael ThomasChief Financial Officer
NRGVEnergy Vault Holdings, Inc.
Option exercise
M$59K
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

8
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Tax withholding
F$122K
10.1K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

7
CA
Cannestra AnthonyDirector
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$198K
3,900 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

6
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$124K
40.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

6
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$119K
10.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence